Inventiva IVEVF
NASDAQ IVEVF
$3.59 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Inventiva (IVEVF) Cash from Operations (2019 - 2025)

Inventiva (IVEVF) posted Cash from Operations of $121.6 million for Q2 2025, up 333.64% on a QoQ basis from -$52.1 million in Q2 2024, and up 333.64% year-over-year from $28.0 million in Q2 2024.

Analysis

Inventiva (IVEVF) Cash from Operations (2019 - 2025) Analysis & Trends

Inventiva has reported Cash from Operations for 6 years, with the latest figure at $121.6 million in Q2 2025.

  • On a quarterly basis, Cash from Operations rose 333.64% year-over-year to $121.6 million in Q2 2025; TTM through Jun 2025 was $15.5 million, a 112.0% increase from a year earlier, with the FY2025 full-year figure at -$122.1 million, down 32.96% from the prior year.
  • Cash from Operations was $121.6 million for Q2 2025 at Inventiva, up from -$52.1 million in the prior quarter.
  • The five-year high for Cash from Operations was $121.6 million in Q2 2025, with the low at -$52.1 million in Q2 2024.
  • Average Cash from Operations over 4 years is -$4.4 million, with a median of -$22.6 million recorded in 2021.
  • The sharpest annual moves came in 2021 and 2025: Cash from Operations tumbled 265.59% in 2021, then surged 333.64% in 2025.
  • Over 4 years, Cash from Operations stood at -$22.6 million in 2021, then retreated by 18.15% to -$26.8 million in 2022, then tumbled by 94.6% to -$52.1 million in 2024, then surged by 333.64% to $121.6 million in 2025.
  • The last three Cash from Operations figures came in at $121.6 million (Q2 2025), -$52.1 million (Q2 2024), and -$26.8 million (Q4 2022), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 Johnson & Johnson 645.47 Bn 624.71 Bn 17.26 Bn 8.62 Bn
2 AbbVie 439.99 Bn 433.42 Bn 12.70 Bn 3.44 Bn
3 Merck 365.45 Bn 358.31 Bn 12.21 Bn 5.37 Bn
4 Novartis Ag 266.57 Bn 258.88 Bn 11.24 Bn 5.88 Bn
5 Pfizer 159.03 Bn 147.33 Bn 10.94 Bn 835.00 Mn
6 Sanofi 52.43 Bn 45.05 Bn 10.79 Bn 3.44 Bn
7 Revolution Medicines 44.23 Bn 44.23 Bn - -387.32 Mn
8 Incyte 25.32 Bn 20.79 Bn 1.57 Bn 507.66 Mn
9 United Therapeutics 21.44 Bn 18.77 Bn 683.80 Mn 313.60 Mn
10 Inventiva 693.72 Mn 693.72 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 121.63 Mn
Jun 30, 2024 -52.06 Mn
Dec 31, 2022 -26.75 Mn
Sep 22, 2022 -27.36 Mn
Dec 31, 2021 -22.64 Mn
Jun 30, 2021 -14.46 Mn
Mar 31, 2021 -9.39 Mn
Dec 31, 2020 -8.55 Mn
Jun 30, 2020 -3.96 Mn
Mar 31, 2020 -3.95 Mn
Dec 31, 2019 -20.66 Mn